We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Neurological Disease Traced to Gene Error

By LabMedica International staff writers
Posted on 15 Aug 2017
A severe neurological rare disorder in children is characterized by developmental regression and neurodegeneration and at first the children lead normal lives and seem identical to their age-matched peers.

However, beginning at around three to six years of age, these children present with neurological deterioration, gradually losing motor, cognitive and speech functions. More...
Although the condition progresses slowly, most patients are completely dependent on their caretakers by 15 to 20 years of age.

A multinational team of scientists collaborating with those at those at the Hebrew University Hadassah Medical School (Jerusalem, Israel) identified and studied seven children, from Canada, France, Israel, Russia and the USA, who suffer from the disorder. They found in all patients the same spontaneously occurring, non-inherited genetic change in the upstream binding transcription factor (UBTF) gene responsible for ribosomal ribonucleic acid (rRNA) formation. Because of this small change, the patients' cells are flooded with ribosomal RNA and are poisoned by it.

In seven unrelated affected individuals, all suffering from developmental regression starting at 2.5 to 7 years, the team using deep sequencing technology, identified a heterozygous variant, c.628G>A in UBTF, encoding p.Glu210Lys in UBF, which occurred de novo in all cases. The team found an identical error in the same gene in all the patients tested, representing a difference of one letter among the roughly three billion letters that make up human DNA. By finding the identical change in children who suffer from the identical clinical disease, the scientists determined that the altered gene is indeed the cause of the disease.

Orly Elpeleg, MD, a professor and head of the Department of Genetics, and senior author of the study, said, “Our study links neuronal degeneration in childhood with altered rDNA chromatin status and rRNA metabolism. It is the first time that an excess of ribosomal RNA has been linked to a genetic disease in humans.” The study was published on August 3, 2017, in The American Journal of Human Genetics.

Related Links:
Hebrew University Hadassah Medical School


Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.